✉news TechnologyTechnology first seen 10 h ago, last 10 h ago, peak #26
AbbVie wins FDA approval for new Parkinson's drug Juvmo
Original: AbbVie lands FDA approval for next-generation Parkinson’s drug, Juvmo
AbbVie has received US Food and Drug Administration approval for Juvmo, described as a next-generation treatment for Parkinson's disease. The decision adds a new option to AbbVie's neurology portfolio and gives patients and doctors an additional therapy for managing the progressive movement disorder.
Why now: FDA approval of a major pharmaceutical company's new Parkinson's treatment is significant news for patients, investors and the medical community.
AbbVieFDAJuvmoParkinson's disease
Evidence
- AbbVie lands FDA approval for next-generation Parkinson’s drug, Juvmo · Pharmaceutical Technology
API: https://socialmediatrends-api.osmike.com/v1/trends/234938